Lindsey McClelland

Geschäftsführer bei Oxeia Biopharmaceuticals, Inc.

Health Technology

Consumer Services

Health Services

Profil

Lindsey McClelland is currently the Vice President-Operations at Oxeia Biopharmaceuticals, Inc. Prior to this, Lindsey worked as the Director-Program Management at Onebiopharma, Inc. Lindsey's education includes an undergraduate degree from Boston College.

Aktive Positionen von Lindsey McClelland

Unternehmen	Position	Beginn
Oxeia Biopharmaceuticals, Inc. Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA.	Geschäftsführer	01.11.2021

Alle aktiven Positionen von Lindsey McClelland

Ehemalige bekannte Positionen von Lindsey McClelland

Unternehmen	Position	Ende
Onebiopharma, Inc. Onebiopharma, Inc. Medical/Nursing ServicesHealth Services Onebiopharma, Inc. provides health care services. The company is headquartered in Boston, MA.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Lindsey McClelland im Detail an

Ausbildung von Lindsey McClelland

Boston College

Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Lindsey McClelland im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Oxeia Biopharmaceuticals, Inc. Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA.	Health Technology
Onebiopharma, Inc. Onebiopharma, Inc. Medical/Nursing ServicesHealth Services Onebiopharma, Inc. provides health care services. The company is headquartered in Boston, MA.	Health Services